DEPRESSION OF CELL-MEDIATED-IMMUNITY IN PLASMACYTOMA-BEARING MICE

被引:2
作者
RUSZALAMALLON, V [1 ]
SILVA, J [1 ]
LUMANGLAS, AL [1 ]
DURR, FE [1 ]
WANG, BS [1 ]
机构
[1] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,CHEMOTHERAPY RES DEPT,TUMOR IMMUNOL LAB,PEARL RIVER,NY 10965
关键词
D O I
10.1038/icb.1991.3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Previous reports have documented that mice bearing plasmacytomas (PC) are suppressed in their ability to mount a primary antibody response, whereas cellular immunity appears to be normal. Studies presented here provide evidence that T cell responsiveness is also depressed in BALB/c mice bearing the Lieberman plasmacytoma (Lpc-1). For instance, splenocytes from mice bearing large tumours were impaired in their in vitro ability to respond to the T cell mitogen, mount an appropriate alloreactive cytolytic T lymphocyte response, and produce interleukin-2 (IL-2). A population of suppressor cells was detected in the spleens 7 days after tumour implantation as evidenced by their ability to prevent normal splenocytes not only from responding to antigens in mixed lymphocyte culture, but also from producing IL-2. A similar inhibitory effect was observed with culture supernatants of these cells, indicating the existence of a soluble suppressive factor. Therefore, the present study demonstrates that cellular immune responses are impaired in mice bearing Lpc-l tumours and that this effect may be due to the generation of suppressor cells and/or a suppressive factor.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 26 条
[1]  
AYANLARBATUMAN O, 1986, BLOOD, V67, P279
[2]  
CHEN YH, 1984, CLIN EXP IMMUNOL, V57, P171
[3]   MANAGING COMPLICATIONS OF PLASMA-CELL MYELOMA [J].
COHEN, HJ ;
RUNDLES, W .
ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (01) :177-184
[4]  
COMMES T, 1986, CLIN EXP IMMUNOL, V63, P533
[5]   IMMUNOLOGICAL DEFICIENCY DISORDERS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA + MULTIPLE MYELOMA [J].
CONE, L ;
UHR, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (12) :2241-&
[6]   INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA [J].
FAHEY, JL ;
SCOGGINS, R ;
UTZ, JP ;
SZWED, CF .
AMERICAN JOURNAL OF MEDICINE, 1963, 35 (05) :698-+
[7]  
FAHEY JL, 1962, IMMUNOLOGY, V5, P110
[8]   THE BIOCHEMISTRY, BIOLOGY, AND ROLE OF INTERLEUKIN-2 IN THE INDUCTION OF CYTO-TOXIC T-CELL AND ANTIBODY-FORMING B-CELL RESPONSES [J].
FARRAR, JJ ;
BENJAMIN, WR ;
HILFIKER, ML ;
HOWARD, M ;
FARRAR, WL ;
FULLERFARRAR, J .
IMMUNOLOGICAL REVIEWS, 1982, 63 :129-166
[9]   ACTIVATION OF SUPPRESSOR T CELLS BY TUMOR-CELLS AND SPECIFIC ANTIBODY [J].
GERSHON, RK ;
MOKYR, MB ;
MITCHELL, MS .
NATURE, 1974, 250 (5467) :594-596
[10]   A REVIEW OF 51 CASES OF MULTIPLE MYELOMA - EMPHASIS ON PNEUMONIA AND OTHER INFECTIONS AS COMPLICATIONS [J].
GLENCHUR, H ;
ZINNEMAN, HH ;
HALL, WH .
ARCHIVES OF INTERNAL MEDICINE, 1959, 103 (02) :173-183